Nancy Marie Allen LaPointe, PharmD

Adjunct Associate Professor in the Department of Medicine
Member in the Duke Clinical Research Institute
Campus mail Remote, Raleigh, NC 27607
Email address

Dr. Allen LaPointe is an Adjunct Associate Professor in Medicine and Faculty Fellow at the Duke-Margolis Center for Health Policy at Duke University.  She is a researcher and cardiovascular clinical pharmacist with extensive experience in health outcomes and health services research, evidence synthesis, and the protection of human research subjects.  Her clinical and research work have been focused on patient safety, predominately in patients with cardiovascular disease.  This includes work in reducing medication errors, improving medication adherence, safely and effectively translating evidence into clinical practice, comparing safety and effectiveness of therapeutics, evaluating risk communication and mitigation strategies, and exploring the interface between health policy and patient safety.  

Education and Training

  • M.H.S., Duke University, 2013
  • Pharm.D., Purdue University, 1988


Allen, N. M., G. D. Dunham, J. M. Sailstad, and J. W. Findlay. “Clinical and pharmacokinetic profiles of digoxin immune Fab in four patients with renal impairment.” Dicp 25, no. 12 (December 1991): 1315–20.

Full Text

Allen, N. M. “Retreatment with digoxin immune Fab.” Clin Pharm 10, no. 11 (November 1991): 823–24.


Sanders, Gillian D., Angela Lowenstern, Ethan Borre, Ranee Chatterjee, Adam Goode, Lauren Sharan, Nancy M Allen LaPointe, et al. “Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update.” Agency for Healthcare Resarch and Quality (AHRQ), n.d.

Full Text

Veeranki, S. P., Z. Xiao, A. Levorsen, M. Sinha, Nancy Allen LaPointe, and B. Shah. “A real world comparative effectiveness analysis of thromboprophylactic use of enoxaparin versus unfractionated heparin among medically ill and abdominal surgery patients in a large US hospital database,” n.d.

Full Text